Christian S. Adonizio
Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Christian S. Adonizio

Hematology | Oncology
Geisinger Health System
Geisinger Wyoming Valley Medical Center - Hematology And Oncology Genetics
1000 East Mountain Boulevard, 
Wilkes Barre, PA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth

Experienced in WT1-Related Wilms Tumor Syndromes
Geisinger Health System
Geisinger Wyoming Valley Medical Center - Hematology And Oncology Genetics
1000 East Mountain Boulevard, 
Wilkes Barre, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dr. Adonizio is a board-certified and fellowship-trained cancer physician specializing in benign hematology and supportive oncology. He obtained his medical degree from Thomas Jefferson University. He completed his residency at Lankenau Hospital, and a combined fellowship in hematology and medical oncology at Fox Chase Cancer Center and Temple University in Philadelphia. Dr. Adonizio is certified by the American Board of Internal Medicine in internal medicine, hematology and medical oncology. He serves as a medical director for the Center for Oncology Research and Innovation at Geisinger.

Dr. Adonizio is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Iron Deficiency Anemia, Acute Lymphoblastic Leukemia (ALL), Childhood Iron Deficiency Anemia, and Acute Mountain Sickness.

His clinical research consists of co-authoring 9 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Jefferson Medical College Of Thomas Jefferson Univ, 1996 - Doctor Of Medicine
Residency
Lankenau Hospital, 1999
Specialties
Hematology
Oncology
Licenses
Internal Medicine in PA
Board Certifications
The American Board Of Internal Medicine In Internal Medicine, Hematology And Medical Oncology
Fellowships
Fox Chase Cancer Center, 2002
Temple University Hospital, 2002
Hospital Affiliations
Geisinger Wyoming Valley Medical Center
Geisinger Medical Center
Geisinger-Community Medical Center
Geisinger-Bloomsburg Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Avalon Health Care
  • MEDICARE PDP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Geisinger Wyoming Valley Medical Center - Hematology and Oncology Genetics
1000 East Mountain Boulevard, Wilkes Barre, PA 18711
Call: 800-275-6401

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Enrollment Status: Recruiting
Publish Date: January 26, 2026
Intervention Type: Other
Study Phase: Not Applicable
Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
A Randomized Phase II Trial of Intermittent Versus Continuous Dosing of Dabrafenib (NSC-763760) and Trametinib (NSC-763093) in BRAF V600E/K Mutant Melanoma
A Randomized Phase II Trial of Intermittent Versus Continuous Dosing of Dabrafenib (NSC-763760) and Trametinib (NSC-763093) in BRAF V600E/K Mutant Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Procedure, Drug
Study Drugs: Dabrafenib Mesylate, Trametinib Dimethyl Sulfoxide
Study Phase: Phase 2
Longitudinal Assessment of Financial Burden in Patients With Colon or Rectal Cancer Treated With Curative Intent
Longitudinal Assessment of Financial Burden in Patients With Colon or Rectal Cancer Treated With Curative Intent
Enrollment Status: Active_not_recruiting
Publish Date: February 11, 2026
Intervention Type: Other
A Randomized Phase II Trial of Ipilimumab With or Without Bevacizumab in Patients With Unresectable Stage III or Stage IV Melanoma
A Randomized Phase II Trial of Ipilimumab With or Without Bevacizumab in Patients With Unresectable Stage III or Stage IV Melanoma
Enrollment Status: Completed
Publish Date: December 11, 2025
Intervention Type: Biological
Study Drugs: Bevacizumab, Ipilimumab
Study Phase: Phase 2
A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer
A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drugs: Gemcitabine, Cisplatin, Methotrexate, Vinblastine, Doxorubicin, Filgrastim
Study Phase: Phase 2
Implementation of a Prospective Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer
Implementation of a Prospective Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer
Enrollment Status: Completed
Publish Date: January 26, 2023
Intervention Type: Other
View 6 Less Clinical Trials

9 Total Publications

Breadth and Depth of Patient and Caregiver Supportive Services in Community Oncology (WF-1803CD).
Breadth and Depth of Patient and Caregiver Supportive Services in Community Oncology (WF-1803CD).
Journal: Psycho-oncology
Published: July 16, 2024
View All 9 Publications
Similar Doctors
Suresh G. Nair
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Suresh G. Nair
Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Suresh G. Nair
Hematology | Oncology

LVH Hematology Oncology-1240 Cedar Crest

1240 S Cedar Crest Blvd, Suite 401, 
Allentown, PA 
 (49.9 miles away)
610-402-7880
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Philosophy of care | Personalized care starts during my first meeting with a patient and family. That's when I get to know the patient as completely as possible. I want to know about the patient's concerns, values and support system so I can provide care that is specific to him or her. | Also, I am a member of the skin and soft tissue cancer multidisciplinary consultation team. Together we review your diagnostic information and give you a written opinion reflecting the scope of your condition and recommendations for your best course of care. | Why I entered medicine | When I was young, I didn't like seeing doctors. It created a lot of anxiety for me. Now that I'm older, I can relate to the way people feel, especially when they're coping with the emotions caused by a serious condition like cancer. My grandmother died of uterine cancer in the 1960s. During her battle, I felt helpless. That is what attracted me to cancer research. Now I see the amazing progress we are making through cancer research. | Community involvement | I served on the state board of the American Cancer Society. Today, I take more of a grassroots approach to offer my support. I participate in events, such as 5K runs, that benefit charities. Dr. Nair is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Melanoma, Adult Soft Tissue Sarcoma, Clear Cell Sarcoma, and WT1-Related Wilms Tumor Syndromes.

Maged F. Khalil
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Maged F. Khalil
Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Maged F. Khalil
Hematology | Oncology

LVH Hematology Oncology-1240 Cedar Crest

1240 S Cedar Crest Blvd, Suite 401, 
Allentown, PA 
 (49.9 miles away)
610-402-7880
Languages Spoken:
English, Arabic
See accepted insurances

Philosophy of care | I am a member of the GI cancer multidisciplinary consultation team. Together we review your diagnostic information and give you a written opinion reflecting the scope of your condition and recommendations for your best course of care. Dr. Khalil is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Gastroesophageal Junction Cancer, Anal Cancer, and Bone Marrow Aspiration.

Zeeshan Hafeez
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Zeeshan Hafeez
Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Zeeshan Hafeez
Hematology | Oncology

LVH Hematology Oncology-Muhlenberg

2545 Schoenersville Road, Suite 300, 
Bethlehem, PA 
 (47.1 miles away)
484-884-5733
Languages Spoken:
English
See accepted insurances

Philosophy of care | My approach to care is rooted in patient-centered, personalized treatment tailored to your unique needs. While I rely on evidence-based practices, I am passionate about integrating the latest advancements in cancer research. I strive for compassionate care and meaningful personal connections. My commitment lies in building trusting, collaborative relationships and empowering you through education and shared decision-making to actively participate in your care. | Why I entered medicine | I entered medicine because of a deep desire to make a meaningful difference in people's lives. The opportunity to combine science, problem-solving and human connection to improve health and alleviate suffering inspired me to pursue this path. | Community involvement | I am engaged with my local community, focusing on raising awareness about cancer prevention and promoting the importance of a healthy lifestyle. | Personal interests | I truly cherish moments with family and friends; they bring so much joy and fulfillment to my life. One of my favorite activities is playing chess with my son. It’s always a fun way to engage in friendly competition and stimulate our minds. When it’s time to relax, I love watching Netflix and sports. Dr. Hafeez is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Chromophobe Renal Cell Carcinoma, Familial Wilms Tumor 2, Clear Cell Sarcoma, and Wilms Tumor.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Adonizio's expertise for a condition
ConditionClose
        • Experienced
        • Acute Eosinophilic Pneumonia
          Dr. Adonizio is
          Experienced
          . Learn about Acute Eosinophilic Pneumonia.
          See more Acute Eosinophilic Pneumonia experts
        • Acute Hepatic Porphyria (AHP)
          Dr. Adonizio is
          Experienced
          . Learn about Acute Hepatic Porphyria (AHP).
          See more Acute Hepatic Porphyria (AHP) experts
        • Acute Lymphoblastic Leukemia (ALL)
          Dr. Adonizio is
          Experienced
          . Learn about Acute Lymphoblastic Leukemia (ALL).
          See more Acute Lymphoblastic Leukemia (ALL) experts
        • Acute Mountain Sickness
          Dr. Adonizio is
          Experienced
          . Learn about Acute Mountain Sickness.
          See more Acute Mountain Sickness experts
        • Acute Myeloblastic Leukemia with Maturation
          Dr. Adonizio is
          Experienced
          . Learn about Acute Myeloblastic Leukemia with Maturation.
          See more Acute Myeloblastic Leukemia with Maturation experts
        • Acute Myeloblastic Leukemia without Maturation
          Dr. Adonizio is
          Experienced
          . Learn about Acute Myeloblastic Leukemia without Maturation.
          See more Acute Myeloblastic Leukemia without Maturation experts
        View All 108 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile
        For Patients
        • Our Story
        • How MediFind Works
        • Conditions A-Z
        • Doctor Directory
        • Symptoms Directory
        • Procedures Directory
        • Treatment Directory
        • Drug Directory
        • Infusion Center Finder
        • FAQ
        • Contact Us
        For Providers and Practices
        • Claim Your Profile
        • Newsroom
        Business Solutions
        • Provider
        • Network Solutions
        Additional Resources
        • Consumer Health Data Privacy Policy
        • Privacy Policy
        • Terms of Use
        • Advertising Policy
        • Content Policy
        Subscribe to our newsletter

        Sign up to stay informed about MediFind and get wellness sent your way.

        Close

          By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

          Bullet PinMediFind
          Follow us on
          This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
          © 2026 All Rights Reserved